广联达(002410) - 2022 Q1 - 季度财报

Financial Performance - Revenue for Q1 2022 reached ¥1,123,010,514.36, an increase of 34.65% compared to ¥834,036,024.85 in the same period last year[4] - Net profit attributable to shareholders was ¥108,780,897.31, up 41.91% from ¥76,656,251.98 year-over-year[4] - Basic earnings per share increased by 42.15% to ¥0.0924 from ¥0.0650 in the previous year[4] - Total operating revenue for Q1 2022 reached CNY 1,130,712,105.88, a 33.1% increase from CNY 848,811,626.68 in the same period last year[19] - Operating income was CNY 1,123,010,514.36, up from CNY 834,036,024.85, reflecting a growth of 34.6% year-over-year[20] - Net profit for Q1 2022 was CNY 111,922,266.39, compared to CNY 82,049,811.40 in Q1 2021, marking a 36.3% increase[20] - The net profit attributable to the parent company for Q1 2022 was ¥108,780,897.31, compared to ¥76,656,251.98 in the same period last year, representing an increase of approximately 42%[21] - The total comprehensive income attributable to the parent company for Q1 2022 was ¥31,574,126.75, up from ¥106,242,344.80 in the previous year[21] - The basic earnings per share for Q1 2022 was ¥0.0924, compared to ¥0.0650 in the same period last year, indicating a growth of approximately 42%[21] Cash Flow - Operating cash flow showed a significant decline, with a net outflow of ¥383,987,214.57, worsening by 215.32% compared to a net outflow of ¥121,777,328.48 in the previous year[4] - The net cash flow from operating activities decreased by 215.32% to -383,987,214.57 RMB compared to the same period last year, primarily due to increased personnel costs and cash payments for goods and services[10] - Cash inflow from operating activities for Q1 2022 was ¥690,783,891.89, down from ¥736,114,376.66 in the previous year, reflecting a decrease of about 6.2%[23] - The company reported a decrease in cash received from sales of goods and services, totaling ¥649,569,827.44 in Q1 2022, compared to ¥636,580,519.41 in the previous year[23] - The company experienced a significant increase in cash paid to employees, amounting to ¥720,457,009.69 in Q1 2022, compared to ¥555,899,642.04 in the same period last year, reflecting a rise of approximately 29.6%[23] - The net cash flow from investing activities increased by 98.27% to -2,060,671.32 RMB, mainly due to the maturity of financial products during the reporting period[10] - The net cash flow from financing activities decreased by 223.04% to -170,834,779.19 RMB, attributed to reduced external investments and increased payments for share repurchases[10] Assets and Liabilities - The total assets at the end of the reporting period were ¥9,473,710,468.70, a decrease of 5.90% from ¥10,067,626,141.36 at the end of the previous year[4] - Total liabilities decreased to CNY 3,479,948,698.10 from CNY 3,794,882,433.78, a reduction of 8.3%[18] - The company's equity attributable to shareholders decreased to CNY 5,515,392,331.25 from CNY 5,787,737,027.21, a decline of 4.7%[18] - Accounts receivable increased by 57.53% to ¥779,208,191.49, attributed to rapid revenue growth and longer settlement cycles[7] - Accounts receivable increased to 779,208,191.49 RMB from 494,634,645.36 RMB year-on-year[16] - Inventory increased to 79,091,963.64 RMB from 70,893,930.79 RMB year-on-year[16] - Deferred income tax assets increased to CNY 62,624,255.12 from CNY 28,943,442.14, an increase of 116.4%[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 40,828, with the top ten shareholders holding a combined 56.57% of shares[11] - The largest shareholder, Diao Zhizhong, holds 15.97% of shares, amounting to 190,064,845 shares[11] - The company has invested a total of 266,349.10 million RMB in fundraising projects, with a cumulative investment of 181,718.16 million RMB, representing 68.23% of the total[13] - The company repurchased a total of 13,728,376 shares, accounting for 1.1533% of the total shares, with a total transaction amount of 848,308,718.67 RMB[15] Research and Development - Research and development expenses rose by 20.98% to ¥308,757,522.32, reflecting ongoing investment in technology platforms and new product development[9] - Research and development expenses increased to CNY 308,757,522.32 from CNY 255,223,630.14, a rise of 20.9% year-over-year[20] Other Income - Other income increased by 144.13% to ¥30,775,108.79, mainly due to government subsidies recognized during the reporting period[9]